Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

Authors

Maxine Sun
Firas Abdollah, Henry Ford HealthFollow

Recommended Citation

Sun M, and Abdollah F. Re: Ar-v7 and resistance to enzalutamide and abiraterone in prostate cancer. Eur Urol 2015; 68(1):162-163.

Document Type

Article

Publication Date

7-1-2015

Publication Title

European urology

Keywords

Androstenols/therapeutic use, Drug Resistance, Neoplasm/genetics, Humans, Male, Phenylthiohydantoin/analogs & derivatives, Prostatic Neoplasms/genetics, RNA, Neoplasm/analysis, Receptors, Androgen/genetics

Medical Subject Headings

Androstenols/therapeutic use; Drug Resistance; Neoplasm/genetics; Humans; Male; Phenylthiohydantoin/analogs & derivatives; Prostatic Neoplasms/genetics; RNA; Neoplasm/analysis; Receptors; Androgen/genetics

PubMed ID

26088731

Volume

68

Issue

1

First Page

162

Last Page

163